BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for November 19, 2024

Nov. 19, 2024
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko, Everest, Immutep, Lixa.
Read More

In the clinic for Nov. 18, 2024

Nov. 18, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 89bio, Aurinia, Eyenovia, Janssen, Levicept, Lixa, Omega, Osteal , Pacira.
Read More

In the clinic for November 18, 2024

Nov. 18, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Boston Scientific, Irhythm, Mursla, Nevro, Sequana, Vektor.
Read More

In the clinic for Nov. 15, 2024

Nov. 15, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Curium, Eli Lilly, Eupraxia, Gilead, GSK, Idrx, Immunic, ImmunoCure, Immutep, Inovio, Nuvectis, Sparian, AC Immune, Mediprint, Microbion, Nobias, X4.
Read More

In the clinic for November 15, 2024

Nov. 15, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Eyenovia.
Read More

In the clinic for Nov. 14, 2024

Nov. 14, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adaptimmune, Aileron, Biorestorative, Creative Medical, Syros.
Read More

In the clinic for November 14, 2024

Nov. 14, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Exact Sciences, Harbinger Health, Phenomix Sciences.
Read More

In the clinic for Nov. 13, 2024

Nov. 13, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbisko, Astrazeneca, Code, Gilead, Gritstone, Hookipa, Insilico, Invivyd, Neurogene, Organogenesis, Quince, Spyre, Syndax, Viiv.
Read More

In the clinic for November 13, 2024

Nov. 13, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Intelligent Bio Solutions.
Read More

In the clinic for Nov. 12, 2024

Nov. 12, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Alligator, Aptevo , Beyondspring, Cantargia, Cerevance, Chimerix, Citius, Cue Biopharma, Enterobiotix, Everest Medicines, Marengo, Oncoinvent, Palleon, Relief, Replimune, Resolution, Storm, Tectonic.
Read More
Previous 1 2 … 66 67 68 69 70 71 72 73 74 … 326 327 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 15, 2026.
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Genome sequence map

    EHA 2026: With new lenses, a changing view on pediatric cancers

    BioWorld
    In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
  • Microscopic image of chronic myeloid leukemia

    Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid

    BioWorld
    Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing